Action. Ran a full portfolio triage against strategic value and commercial viability, landing on four dispositions: keep, evolve, research, kill. The hard part was not the analysis — it was that several kill candidates still carried live revenue, so each one needed a migration path rather than a shutdown date. Paired the triage with an operating model change: no new product enters a build sprint without a named first client and a signed-off commercial definition.